Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Share-based Compensation (2017 - 2022)

Historic Share-based Compensation for Iterum Therapeutics (ITRM) over the last 6 years, with Q4 2022 value amounting to $457000.0.

  • Iterum Therapeutics' Share-based Compensation fell 7676.66% to $457000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $4.8 million, marking a year-over-year increase of 1016.44%. This contributed to the annual value of $363000.0 for FY2024, which is 5369.9% down from last year.
  • Per Iterum Therapeutics' latest filing, its Share-based Compensation stood at $457000.0 for Q4 2022, which was down 7676.66% from $422000.0 recorded in Q3 2022.
  • Iterum Therapeutics' 5-year Share-based Compensation high stood at $2.0 million for Q2 2022, and its period low was $126000.0 during Q4 2020.
  • Its 5-year average for Share-based Compensation is $764950.0, with a median of $549500.0 in 2019.
  • Per our database at Business Quant, Iterum Therapeutics' Share-based Compensation skyrocketed by 146111.11% in 2021 and then tumbled by 7676.66% in 2022.
  • Iterum Therapeutics' Share-based Compensation (Quarter) stood at $412000.0 in 2018, then increased by 21.12% to $499000.0 in 2019, then crashed by 74.75% to $126000.0 in 2020, then soared by 1461.11% to $2.0 million in 2021, then crashed by 76.77% to $457000.0 in 2022.
  • Its Share-based Compensation was $457000.0 in Q4 2022, compared to $422000.0 in Q3 2022 and $2.0 million in Q2 2022.